Tab Application Banner
  • Users Online: 680
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Development of the myocite biobank: Cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis

Naveen R, Anuja Anamika Kumari, Rai Mohit Kumar, Agarwal Vikas, Gupta Latika

Year : 2020| Volume: 15| Issue : 6 | Page no: 194-199

   This article has been cited by
 
1 High burden of infections in Indian patients with Idiopathic Inflammatory Myopathy: validation of observations from the MyoCite dataset
Rudrarpan Chatterjee,Pankti Mehta,Vikas Agarwal,Latika Gupta
Rheumatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic
R. Naveen,T. G. Sundaram,Vikas Agarwal,Latika Gupta
Rheumatology International. 2021; 41(1): 67
[Pubmed]  [Google Scholar] [DOI]
3 Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort
R. Naveen,Upendra Rathore,Vikas Agarwal,Latika Gupta
Rheumatology International. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 High early mortality in idiopathic inflammatory myopathies: results from the inception cohort at a tertiary care centre in northern India
Pankti Mehta,Vikas Agarwal,Latika Gupta
Rheumatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Serum fatty acid-binding protein 3 levels differentiate active from inactive myositis and correlate with response to therapy
Latika Gupta,Sanjukta Majumder,Amita Aggarwal,Ramnath Misra,Able Lawrence
Indian Journal of Rheumatology. 2020; 15(6): 187
[Pubmed]  [Google Scholar] [DOI]

 

Read this article